04 November 2025
Coulter Partners places R&D Senior Project Director at Vicore Pharma Holding
Coulter Partners successfully completed a search assignment for Vicore Pharma Holding AB (STO: VICO) and is pleased to announce the placement of Katrine Husum as R&D Senior Project Director.
Vicore Pharma is a clinical-stage pharmaceutical company focused on developing treatments for severe respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). The company is developing a new class of drugs with disease-modifying potential.
Katrine Husum has more than 20 years of experience in the biopharmaceutical industry, specializing in project and alliance management. She has led drug development projects with global cross-functional teams and strategic partnerships across the R&D value chain. Her previous roles include Head of Project and Alliance Management at Nykode Therapeutics and various Project Director roles at Leo Pharma, Takeda and Nycomed.
Commenting on the appointment, Ahmed Mousa, Vicore Pharma’s Chief Executive Officer said: “Identifying the right talent is essential to advancing our mission. We appreciate Coulter Partners’ partnership in understanding our needs and helping us secure a candidate whose expertise will strengthen our ability to deliver meaningful therapies for patients.”
----

Katrine Husum, R&D Senior Project Director at Vicore Pharma
About Vicore Pharma
The company is publicly listed on the Nasdaq Stockholm exchange (VICO).
For more information: www.vicorepharma.com
About Coulter Partners
www.coulterpartners.com
Related
-
Company News
Mission Possible: Sharpening our edge for the unwritten future
26 November 2025
-
Company News
Coulter Partners at the AESC Global Summit on Leadership: Key insights for "The unwritten future"
20 November 2025
-
Company News
Beyond talent: guiding the future of Life Sciences governance at Swiss Board Day
10 November 2025
-
Company News
Coulter Partners at BIO-Europe 2025: driving leadership conversations in Vienna
06 November 2025